의료진/진료과

학력/경력

• 부산대학교 의과대학 졸업
• 부산대학교병원 인턴 수료
• 메리놀병원 레지던트 수료
• 서울대학교 병원 신장내과 전임의
• 분당 서울대병원 신장내과 연구전임의
• 내과 전문의 자격취득
• 신장내과 분과전문의 자격 취득
• 신장투석전문의 자격 취득
• 메리놀 병원 신장내과 과장(2010.03~2021.12)

학회활동

• 대한내과학회 정회원
• 대한이식학회 정회원
• 대한신장학회 정회원
• 미국신장학회 정회원
• 대한투석혈관학회 정회원
• 대한신장학회 인공신장실 인증평가위원

주요 논문(및 저서)

1. 1. 심초음파 검사를 이용하여 진단된 폐동맥 혈전색전증을 동반한 다발성 골수종의 진단의 1예(J. Cardiovasc Imaging, vol 15, no 2, 59-62, 2007)
2. 2. Genetic polymorphisms of epoxide hydrolase and the long-term graft dysfunction after kidney transplantation(ASN, 2008)
3. 3. Activation of Hypoxia-Inducible Factor Attenuates Renal Injury in Gentamicin-induced Acute Renal Injury(대한신장학회, ASN, 2009)
4. 4. The impact of Awareness of Chronic Kidney Disease (CKD) on the Management of Risk Factors for Cardiovascular Morbidity in Korea(대한신장학회, 2009)
5. 5. Interleukin-10 (IL-10) Gene Promoter Polymorphism was Associated with the Progression of Primary Membranous Nephropathy in Korean(대한신장학회, 2009, 우수초록상)
6. 6. Bortezomib for Treatment-resistant Case of Anti-ABO Antibody Mediated Acute Rejection (ABO-AMR)(대한신장학회, 2010)
7. 7. Detection of Hepatocellular Carcinoma by Dual Contrast Magnetic Resonance Imaging in a Patient with Autosomal Dominant Polycystic Kidney Disease(대한신장학회, 2010)
8. 8. ABO Incompatible Living Donor Kidney Transplantation (ABOI-KT) without Splenectomy: Single Center Experience(대한신장학회, 2010)
9. 9. Safety of Six Hour-Admission Kidney Biopsy, A Single-Center Experience(대한신장학회, 2011)
10. 10. Bortezomib for Treatment-Resistant Case of Anti-ABO Antibody Mediated Acute Rejection (ABO-AMR)(대한신장학회, 2011)
11. 11. Hypoxia-Inducible Factor Activation Protects the Kidney from Gentamicin-Induced Acute Injury(Plos one, vol7(11), e48952, 2012 nov)
12. 12. Living Donor Kidney Transplantation from HBsAg (+) Donor to HBsAg (-) Recipient(대한신장학회, 2013)
13. 13. Prevalence and associated Clinical Features of Donor Specific Anti-HLA Ab (DSA) of Renal Allograft Recipients in Late Post Transplant Period(대한신장학회, 2015)
14. 14. De Novo AL Amyloidosis in a Renal Allograft(Korean J Mde, vol 90, no 6, 545-549, 2016)
15. 15. C3d-binding Anti-DQ DSAs are associated with a high risk for lat ABMR and graft failure in stable kidney transplant reicipients(EDTA, 2017)
16. 16. Clinical significance of C3d fixing DSA on ABMR and Graft outcome in kidney transplant recipients(대한내과학회, 2018)
17. 17. A case of vildagliptin induced-Hepatotoxicity in patient after ABOi renal transplantation.(대한내과학회, 2018)
18. 18. 혈액 투석 환자에서 발생한 만성 골수성 백혈병의 이마티닙 치료 증례(대한내과학회, 2018)
19. 19. Denosumab effects on bone turnover markers in hemodialysis patients with osteoporosis(대한내과학회, 2018)
20. 20. Comparison of cognitive impairment in hemodialysis patients with sarcopenia(대한내과학회, 2019)
21. 21. 고령 환자에서 발생한 저칼슘혈증과 관련된 비스포스포네이트 사용의 증례(대한내과학회, 2019)
22. 22. Serial change of serum calcium and management of hypocalcemia after denosumab treatment in hemodailysis patients: single center experience.(ASN, 2019)